103 related articles for article (PubMed ID: 2454366)
1. Studies on the mode of vasodilating action of carvedilol.
Sponer G; Strein K; Müller-Beckmann B; Bartsch W
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S42-8. PubMed ID: 2454366
[TBL] [Abstract][Full Text] [Related]
2. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
Hashimoto H; Kanda A; Hubo H; Tanaka M
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S22-8. PubMed ID: 1721975
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of carvedilol, a compound with beta-blocking and vasodilating properties.
Strein K; Sponer G; Müller-Beckmann B; Bartsch W
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S33-41. PubMed ID: 2454365
[TBL] [Abstract][Full Text] [Related]
4. A new molecule with vasodilating and beta-adrenoceptor blocking properties.
Abshagen U
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S23-32. PubMed ID: 2454364
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
Hashimoto H; Tanaka M; Kanda A; Akashi A
Drugs; 1988; 36 Suppl 6():31-6. PubMed ID: 2908302
[TBL] [Abstract][Full Text] [Related]
6. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Nichols AJ; Gellai M; Ruffolo RR
Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
[TBL] [Abstract][Full Text] [Related]
7. The interaction of the enantiomers of carvedilol with alpha 1- and beta 1-adrenoceptors.
Nichols AJ; Sulpizio AC; Ashton DJ; Hieble JP; Ruffolo RR
Chirality; 1989; 1(4):265-70. PubMed ID: 2577144
[TBL] [Abstract][Full Text] [Related]
8. Blood pressure lowering action and alpha-adrenolytic effect of adimolol in rats.
Palluk R; Hoefke W
Arch Int Pharmacodyn Ther; 1989; 301():215-27. PubMed ID: 2576194
[TBL] [Abstract][Full Text] [Related]
9. Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity.
Feuerstein GZ; Yue TL; Cheng HY; Ruffolo RR
J Hypertens Suppl; 1993 Jun; 11(4):S41-8. PubMed ID: 8104241
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological profile of carvedilol as a beta-blocking agent with vasodilating and hypotensive properties.
Sponer G; Bartsch W; Strein K; Müller-Beckmann B; Böhm E
J Cardiovasc Pharmacol; 1987 Mar; 9(3):317-27. PubMed ID: 2437399
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the risk for drug-induced postural hypotension in an experimental model: investigations with carvedilol, prazosin, labetalol, and guanethidine.
Bartsch W; Sponer G; Strein K; Böhm E; Hooper RG
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S49-51. PubMed ID: 2454367
[TBL] [Abstract][Full Text] [Related]
12. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol.
Hirohashi M; Takasuna K; Tamura K; Yamaguchi K; Maekawa K; Yamada S; Iwasaki S; Yoshida M; Nomura M; Taguchi K
Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393
[TBL] [Abstract][Full Text] [Related]
13. Vascular effects of carvedilol, a new beta-adrenoceptor antagonist with vasodilating properties, in isolated canine coronary artery.
Hattori Y; Nakaya H; Endou M; Nakao Y; Kanno M
J Cardiovasc Pharmacol; 1989 Apr; 13(4):572-9. PubMed ID: 2470994
[TBL] [Abstract][Full Text] [Related]
14. Vasodilatory action of carvedilol.
Sponer G; Strein K; Bartsch W; Müller-Beckmann B
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S5-11. PubMed ID: 1378150
[TBL] [Abstract][Full Text] [Related]
15. Oral administration of carvedilol and prazosin inhibits the prostaglandin F2 alpha- and noradrenaline-induced contraction of human hand veins in vivo.
Beermann C; Schloos J; Belz GG
Clin Investig; 1992; 70 Suppl 1():S13-9. PubMed ID: 1317234
[TBL] [Abstract][Full Text] [Related]
16. Alpha 1-blocking properties of carvedilol during acute and chronic administration.
Giannattasio C; Cattaneo BM; Seravalle G; Carugo S; Mangoni AA; Grassi G; Zanchetti A; Mancia G
J Cardiovasc Pharmacol; 1992; 19 Suppl 1():S18-22. PubMed ID: 1378144
[TBL] [Abstract][Full Text] [Related]
17. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
[TBL] [Abstract][Full Text] [Related]
18. Studies on the antihypertensive properties of carvedilol, a compound with beta-blocking and vasodilating effects.
Tanaka M; Masumura H; Tanaka S; Akashi A
J Cardiovasc Pharmacol; 1987; 10 Suppl 11():S52-7. PubMed ID: 2454368
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive and beta-adrenoceptor blocking properties of 3,4-dihydro-8-(2-hydroxy-3-isopropylamino) propoxy-3-nitroxy-2H-1-benzopyran (K-351), a new antihypertensive agent.
Uchida Y; Nakamura M; Shimizu S; Shirasawa Y; Fujii M
Arch Int Pharmacodyn Ther; 1983 Mar; 262(1):132-49. PubMed ID: 6135395
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger.
Yue TL; Cheng HY; Lysko PG; McKenna PJ; Feuerstein R; Gu JL; Lysko KA; Davis LL; Feuerstein G
J Pharmacol Exp Ther; 1992 Oct; 263(1):92-8. PubMed ID: 1357162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
